Trial Outcomes & Findings for Internal Jugular Vein Compression Collar for Novel Symptomatic Treatment of Venous Pulsatile Tinnitus (NCT NCT05441540)
NCT ID: NCT05441540
Last Updated: 2024-04-16
Results Overview
Assessing the difference in pulsatile tinnitus symptom intensity without the collar vs. with the collar as evaluated by a 10 point Likert scale ranging 0-10 where 0 is no symptoms and 10 is maximal symptom intensity. Participants were allowed to use the collar for up to 30 days as often or as little as desired on a weekly basis but no longer than 2 hours continuously in accordance with the collar's FDA clearance. Participants completed a survey for each day of use reporting the intensity of their symptoms before wearing the collar and while wearing the collar. The difference between these symptom intensities with and without the collar is a single data point. Each data point was aggregated across all participants and across all days of use. From these aggregated data, the median and interquartile range were calculated. Therefore, the outcome is the median difference in intensity before and during wear of every day of collar use by every participant.
COMPLETED
NA
20 participants
From immediately before collar placement to less than or equal to two hours of wearing the collar for each day of use.
2024-04-16
Participant Flow
Participant milestones
| Measure |
Treatment Group
Device will be fitted and worn up to two hours daily and participants will log changes in symptom intensity before and during device usage
Internal Jugular Vein Compression Collar: The current FDA approved internal jugular vein compression collar, marketed as the Q collar, is manufactured by Q30 Innovations Home. It is designed to be worn around the neck of individuals aged 13 and older. It functions by lightly compressing the internal jugular vein's bilaterally, safely increasing intracranial volume and intracranial pressure. The FDA approved neck collar device is made of a thermoplastic elastomer that is specifically fitted to an individual to provide mild internal jugular vein compression. The product was developed and confirmed with ultrasonography to confirm appropriate fit and compression of the vein based on an athlete's neck circumference.
|
|---|---|
|
Overall Study
STARTED
|
20
|
|
Overall Study
COMPLETED
|
18
|
|
Overall Study
NOT COMPLETED
|
2
|
Reasons for withdrawal
| Measure |
Treatment Group
Device will be fitted and worn up to two hours daily and participants will log changes in symptom intensity before and during device usage
Internal Jugular Vein Compression Collar: The current FDA approved internal jugular vein compression collar, marketed as the Q collar, is manufactured by Q30 Innovations Home. It is designed to be worn around the neck of individuals aged 13 and older. It functions by lightly compressing the internal jugular vein's bilaterally, safely increasing intracranial volume and intracranial pressure. The FDA approved neck collar device is made of a thermoplastic elastomer that is specifically fitted to an individual to provide mild internal jugular vein compression. The product was developed and confirmed with ultrasonography to confirm appropriate fit and compression of the vein based on an athlete's neck circumference.
|
|---|---|
|
Overall Study
Withdrawal by Subject
|
2
|
Baseline Characteristics
Internal Jugular Vein Compression Collar for Novel Symptomatic Treatment of Venous Pulsatile Tinnitus
Baseline characteristics by cohort
| Measure |
Treatment Group
n=18 Participants
Device will be fitted and worn up to two hours daily and participants will log changes in symptom intensity before and during device usage
Internal Jugular Vein Compression Collar: The current FDA approved internal jugular vein compression collar, marketed as the Q collar, is manufactured by Q30 Innovations Home. It is designed to be worn around the neck of individuals aged 13 and older. It functions by lightly compressing the internal jugular vein's bilaterally, safely increasing intracranial volume and intracranial pressure. The FDA approved neck collar device is made of a thermoplastic elastomer that is specifically fitted to an individual to provide mild internal jugular vein compression. The product was developed and confirmed with ultrasonography to confirm appropriate fit and compression of the vein based on an athlete's neck circumference.
|
|---|---|
|
Age, Continuous
|
45 years
STANDARD_DEVIATION 10 • n=39 Participants
|
|
Sex: Female, Male
Female
|
12 Participants
n=39 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=39 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · White
|
15 Participants
n=39 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Black/African American
|
2 Participants
n=39 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Other Race
|
1 Participants
n=39 Participants
|
|
Region of Enrollment
United States
|
18 Participants
n=39 Participants
|
|
Body Mass Index (BMI)
|
26 kg/m^2
STANDARD_DEVIATION 3 • n=39 Participants
|
PRIMARY outcome
Timeframe: From immediately before collar placement to less than or equal to two hours of wearing the collar for each day of use.Assessing the difference in pulsatile tinnitus symptom intensity without the collar vs. with the collar as evaluated by a 10 point Likert scale ranging 0-10 where 0 is no symptoms and 10 is maximal symptom intensity. Participants were allowed to use the collar for up to 30 days as often or as little as desired on a weekly basis but no longer than 2 hours continuously in accordance with the collar's FDA clearance. Participants completed a survey for each day of use reporting the intensity of their symptoms before wearing the collar and while wearing the collar. The difference between these symptom intensities with and without the collar is a single data point. Each data point was aggregated across all participants and across all days of use. From these aggregated data, the median and interquartile range were calculated. Therefore, the outcome is the median difference in intensity before and during wear of every day of collar use by every participant.
Outcome measures
| Measure |
Treatment Group
n=18 Participants
Device will be fitted and worn up to two hours daily and participants will log changes in symptom intensity before and during device usage
Internal Jugular Vein Compression Collar: The current FDA approved internal jugular vein compression collar, marketed as the Q collar, is manufactured by Q30 Innovations Home. It is designed to be worn around the neck of individuals aged 13 and older. It functions by lightly compressing the internal jugular vein's bilaterally, safely increasing intracranial volume and intracranial pressure. The FDA approved neck collar device is made of a thermoplastic elastomer that is specifically fitted to an individual to provide mild internal jugular vein compression. The product was developed and confirmed with ultrasonography to confirm appropriate fit and compression of the vein based on an athlete's neck circumference.
|
|---|---|
|
Change From Baseline in Pulsatile Tinnitus Symptom Intensity
|
3 units on a scale
Interval 1.0 to 4.0
|
SECONDARY outcome
Timeframe: Baseline, 5 weeks later upon completion of study participationDetermine if quality of life changes appreciably while using the collar and participating in the study as measured by the tinnitus handicap inventory (THI), a 25-item validated survey that evaluates the degree of impact a patient's tinnitus has on their quality of life. It is scored on a scale of 0-100, where 0 represents no handicap and 100 represent catastrophic handicap.
Outcome measures
| Measure |
Treatment Group
n=18 Participants
Device will be fitted and worn up to two hours daily and participants will log changes in symptom intensity before and during device usage
Internal Jugular Vein Compression Collar: The current FDA approved internal jugular vein compression collar, marketed as the Q collar, is manufactured by Q30 Innovations Home. It is designed to be worn around the neck of individuals aged 13 and older. It functions by lightly compressing the internal jugular vein's bilaterally, safely increasing intracranial volume and intracranial pressure. The FDA approved neck collar device is made of a thermoplastic elastomer that is specifically fitted to an individual to provide mild internal jugular vein compression. The product was developed and confirmed with ultrasonography to confirm appropriate fit and compression of the vein based on an athlete's neck circumference.
|
|---|---|
|
Change From Baseline in Tinnitus Quality of Life From Collar Usage
|
12 score on a scale
Interval 7.0 to 16.0
|
SECONDARY outcome
Timeframe: From immediately before collar placement to less than or equal to two hours of wearing the collar for each day of use.Participants were allowed to use the collar for up to 30 days as often or as little as desired on a weekly basis but no longer than 2 hours continuously in accordance with the collar's FDA clearance. Participants completed a survey containing a 0-10 point Likert scale of tinnitus intensity (where 0 is no symptoms and 10 is maximal symptom intensity) for each day of use reporting the intensity of their symptoms before wearing the collar and while wearing the collar. The difference between these symptom intensities with and without the collar is a single data point. These data points were grouped by week (week 1, week 2, week 3, week 4) across participants and the median for each reported. These medians were compared statistically to determine if the effect of the collar on symptom intensity changed by week.
Outcome measures
| Measure |
Treatment Group
n=18 Participants
Device will be fitted and worn up to two hours daily and participants will log changes in symptom intensity before and during device usage
Internal Jugular Vein Compression Collar: The current FDA approved internal jugular vein compression collar, marketed as the Q collar, is manufactured by Q30 Innovations Home. It is designed to be worn around the neck of individuals aged 13 and older. It functions by lightly compressing the internal jugular vein's bilaterally, safely increasing intracranial volume and intracranial pressure. The FDA approved neck collar device is made of a thermoplastic elastomer that is specifically fitted to an individual to provide mild internal jugular vein compression. The product was developed and confirmed with ultrasonography to confirm appropriate fit and compression of the vein based on an athlete's neck circumference.
|
|---|---|
|
Temporality of Collar Usage Effect on Symptom Intensity
Week 1
|
2 units on a scale
Interval 1.0 to 3.0
|
|
Temporality of Collar Usage Effect on Symptom Intensity
Week 2
|
2 units on a scale
Interval 2.0 to 3.0
|
|
Temporality of Collar Usage Effect on Symptom Intensity
Week 3
|
2 units on a scale
Interval 1.0 to 3.0
|
|
Temporality of Collar Usage Effect on Symptom Intensity
Week 4
|
3 units on a scale
Interval 1.25 to 3.0
|
SECONDARY outcome
Timeframe: From immediately before collar placement to less than or equal to two hours of wearing the collar for each day of use.Assessing the difference in pulsatile tinnitus symptom intensity without the collar vs. with the collar as evaluated by a 10 point Likert scale ranging 0-10 where 0 is no symptoms and 10 is maximal symptom intensity. Participants were allowed to use the collar for up to 30 days as often or as little as desired on a weekly basis but no longer than 2 hours continuously in accordance with the collar's FDA clearance. Participants completed a survey for each day of use reporting the intensity of their symptoms before wearing the collar and while wearing the collar. The difference between these symptom intensities with and without the collar is a single data point. Each of these data points were grouped by location of measurement (in clinic vs. at-home) across participants, the medians of each of these two groups were reported, and then statistically compared to evaluate if the change in symptom intensity varied by location of measurement.
Outcome measures
| Measure |
Treatment Group
n=18 Participants
Device will be fitted and worn up to two hours daily and participants will log changes in symptom intensity before and during device usage
Internal Jugular Vein Compression Collar: The current FDA approved internal jugular vein compression collar, marketed as the Q collar, is manufactured by Q30 Innovations Home. It is designed to be worn around the neck of individuals aged 13 and older. It functions by lightly compressing the internal jugular vein's bilaterally, safely increasing intracranial volume and intracranial pressure. The FDA approved neck collar device is made of a thermoplastic elastomer that is specifically fitted to an individual to provide mild internal jugular vein compression. The product was developed and confirmed with ultrasonography to confirm appropriate fit and compression of the vein based on an athlete's neck circumference.
|
|---|---|
|
Observed Clinical Effect of Collar vs. Home Use Effect of Collar
Clinic Measurement
|
2 units on a scale
Interval 1.0 to 3.0
|
|
Observed Clinical Effect of Collar vs. Home Use Effect of Collar
Home Measurement
|
3 units on a scale
Interval 2.0 to 3.0
|
Adverse Events
Treatment Group
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place